Wird geladen...
ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion
Glioblastoma (GBM) is the most aggressive primary intracranial tumor in adults. Chemoradiotherapy resistance and recurrence after surgery are the main malignant progression factors, leading to a high mortality rate. Therefore, the exploration of novel biomarkers and molecular mechanisms of GBM is ur...
Gespeichert in:
| Veröffentlicht in: | Oncol Rep |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
D.A. Spandidos
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160549/ https://ncbi.nlm.nih.gov/pubmed/32323832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2020.7573 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|